BHCM
PGEN icon

Brevan Howard Capital Management’s Precigen PGEN Stock Holding History

Brevan Howard Capital Management’s Portfolio PGEN Stock Details PGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-26,267
Closed -$110K – 2404
2025
Q4 		$110K Sell
26,267
-97,475
-79% -$377K ﹤0.01% 1670
2025
Q3 		$407K Buy
+123,742
New +$349K ﹤0.01% 1394

Other funds holding PGEN

PCM
Patient Capital Management Baltimore, Maryland $2.74B AUM 43.59% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DC
Diametric Capital Boston, Massachusetts $385M AUM 31.69% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
OCM
Occam Crest Management Darien, Connecticut $165M AUM
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

Brevan Howard Capital Management's PGEN Position: Q1 2026 in Review

Brevan Howard Capital Management sold out of Precigen (PGEN) in Q1 2026, closing a stake of 26,267 shares — an estimated $110K sold.

Brevan Howard Capital Management first reported a position in PGEN in Q3 2025 and held it in 2 quarters. The position peaked at $407K in Q3 2025. 205 funds tracked by Wall St. Rank hold PGEN as of Q1 2026.

  • Brevan Howard Capital Management reported no remaining Precigen position as of Q1 2026 after selling out during the quarter.
  • Brevan Howard Capital Management sold 26,267 Precigen shares in Q1 2026, an estimated $110K.
  • Brevan Howard Capital Management first reported a position in Precigen in Q3 2025 and held it in 2 quarters.
  • Brevan Howard Capital Management's Precigen position peaked at $407K in Q3 2025.
  • 205 funds tracked by Wall St. Rank held Precigen as of Q1 2026.

Based on Brevan Howard Capital Management's 13F filing for Q1 2026, filed 15 May 2026.